Hopkins neuroscientist Richard Huganir is close to finding a potential life-changing treatment for kids with SYNGAP1-related disorders, but cuts to federal funding could delay or halt the progress ...

The drugs treat disorders such as anxiety, panic attacks and insomnia, but stopping them abruptly can compound users’ ...